AU2418499A - Org-5222 in the treatment of depression - Google Patents
Org-5222 in the treatment of depressionInfo
- Publication number
- AU2418499A AU2418499A AU24184/99A AU2418499A AU2418499A AU 2418499 A AU2418499 A AU 2418499A AU 24184/99 A AU24184/99 A AU 24184/99A AU 2418499 A AU2418499 A AU 2418499A AU 2418499 A AU2418499 A AU 2418499A
- Authority
- AU
- Australia
- Prior art keywords
- org
- depression
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97204026 | 1997-12-19 | ||
EP97204026 | 1997-12-19 | ||
PCT/EP1998/008539 WO1999032108A1 (en) | 1997-12-19 | 1998-12-15 | Org-5222 in the treatment of depression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2418499A true AU2418499A (en) | 1999-07-12 |
Family
ID=8229089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU24184/99A Abandoned AU2418499A (en) | 1997-12-19 | 1998-12-15 | Org-5222 in the treatment of depression |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2418499A (en) |
WO (1) | WO1999032108A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060084692A1 (en) * | 2004-10-15 | 2006-04-20 | Pfizer Inc. | Treatment of bipolar disorders and associated symptoms |
ES2333980T3 (en) | 2005-04-07 | 2010-03-03 | N.V. Organon | INTERMEDIATE COMPOUNDS USEFUL IN THE PREPARATION OF TRANS-5-CHLORINE-2-METHYL-2,3,3A, 12B-TETRAHYDRO-1H-DIBENZO (2,3: 6,7) OXEPINO (4,5-C) PIRROL. |
PL1917267T3 (en) * | 2005-04-07 | 2009-06-30 | Merck Sharp & Dohme | Crystal form of asenapine maleate |
US7872147B2 (en) | 2005-04-07 | 2011-01-18 | N. V. Organon | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
US7741358B2 (en) | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
US7750167B2 (en) | 2006-07-05 | 2010-07-06 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process |
US7875729B2 (en) | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
WO2009135091A1 (en) * | 2008-04-30 | 2009-11-05 | Medivation Technologies, Inc. | Use of asenapine and related compounds for the treatment of neuronal or non-neuronal diseases or conditions |
JP5815702B2 (en) | 2010-07-29 | 2015-11-17 | ラボラトリオス レスヴィ,エス.エル. | A novel method for manufacturing asenapine |
WO2016198113A1 (en) | 2015-06-11 | 2016-12-15 | Alrise Biosystems Gmbh | Process for the preparation of drug loaded microparticles |
CN115813888A (en) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | Transdermal therapeutic system comprising asenapine |
KR102614709B1 (en) | 2016-12-20 | 2023-12-18 | 에르테에스 로만 테라피-시스테메 아게 | Transdermal absorption treatment system containing asenapine and polysiloxane or polyisobutylene |
JP2020525545A (en) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | Transdermal therapeutic system containing asenapine and silicone-acrylic hybrid polymer |
KR20210022656A (en) | 2018-06-20 | 2021-03-03 | 에르테에스 로만 테라피-시스테메 아게 | Transdermal treatment system containing acenapine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL178593C (en) * | 1974-01-31 | 1986-04-16 | Akzo Nv | PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BASED ON A TETRACYCLIC COMPOUND AND METHOD FOR PREPARING THE TETRACYCLIC COMPOUNDS TO BE USED THEREOF |
IE62754B1 (en) * | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants |
CZ284633B6 (en) * | 1994-03-02 | 1999-01-13 | Akzo Nobel N. V. | PHARMACEUTICAL PREPARATION AND USE OF TRANS-5-CHLORO-2-METHYL-2,3,3a,12b-TETRAHYDRO-1H-DIBENZ[2,3:6,7]OXEPINO [4,5-c]PYRROLE FOR PREPARING THE PHARMACEUTICAL PREPARATION |
JP3274579B2 (en) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | Agent for treating psychiatric symptoms associated with cerebrovascular disorders |
-
1998
- 1998-12-15 WO PCT/EP1998/008539 patent/WO1999032108A1/en active Application Filing
- 1998-12-15 AU AU24184/99A patent/AU2418499A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999032108A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPO203996A0 (en) | Therapeutic uses | |
AU9790198A (en) | Compounds and methods | |
AU9781998A (en) | Huchordin and uses thereof | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
AU2418499A (en) | Org-5222 in the treatment of depression | |
AU2387097A (en) | Substituted benzylamines and their use for the treatment of depression | |
AU8695298A (en) | Compounds and uses thereof | |
AU6300898A (en) | Well treatment with particles | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU1538499A (en) | Body ornament | |
AU4629399A (en) | Substituted piperazones and their therapeutic uses | |
AU7759698A (en) | Hair treatment agents | |
AU1171099A (en) | Therapeutic agents | |
AU1645599A (en) | Human matrilin-3 | |
AU8155898A (en) | Human preprotachykinin b | |
AU8693198A (en) | Compounds and uses thereof | |
AU5386498A (en) | Enhancement phalloplasty | |
AU7641098A (en) | Therapeutic composition | |
AU7583998A (en) | Human chemokine zchemo-8 | |
AU2713797A (en) | Depigmentating agent in the treatment of melasma | |
AU2708597A (en) | An improvement in the treatment of wastes | |
AUPO852797A0 (en) | Enhancement phalloplasty | |
AU6409598A (en) | An improvement in the treatment of wastes | |
AU6871798A (en) | Human chemokine zsig-35 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |